Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-01 @ 4:59 PM
Study NCT ID:
NCT00759356
Status:
COMPLETED
Last Update Posted:
2010-08-17
First Post:
2008-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions
Sponsor:
Actavis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20-700-1N
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Daniel V. Freeland, DO
Old Organization:
CEDRA Clinical Research, LLC